Guan XY - Search Results

1

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. Ma S, et al. Among authors: guan xy. Oncogene. 2008 Mar 13;27(12):1749-58. doi: 10.1038/sj.onc.1210811. Epub 2007 Sep 24. Oncogene. 2008. PMID: 17891174

2

Hepatitis B virus X gene in the development of hepatocellular carcinoma.

Ma NF, Lau SH, Hu L, Dong SS, Guan XY. Ma NF, et al. Among authors: guan xy. Hong Kong Med J. 2011 Dec;17 Suppl 6:44-7. Hong Kong Med J. 2011. PMID: 22147360 No abstract available.

3

The significance of LMO2 expression in the progression of prostate cancer.

Ma S, Guan XY, Beh PS, Wong KY, Chan YP, Yuen HF, Vielkind J, Chan KW. Ma S, et al. Among authors: guan xy. J Pathol. 2007 Feb;211(3):278-85. doi: 10.1002/path.2109. J Pathol. 2007. PMID: 17167821

4

MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.

Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NPY, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, He QY, Cheung ALM. Li B, et al. Among authors: guan xy. Oncogene. 2017 Jul 13;36(28):3986-4000. doi: 10.1038/onc.2017.29. Epub 2017 Mar 13. Oncogene. 2017. PMID: 28288140 Free PMC article.

5

Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line HKESC-4 of Chinese origin.

Cheung LC, Tang JC, Lee PY, Hu L, Guan XY, Tang WK, Srivastava G, Wong J, Luk JM, Law S. Cheung LC, et al. Among authors: guan xy. Cancer Genet Cytogenet. 2007 Oct 1;178(1):17-25. doi: 10.1016/j.cancergencyto.2007.05.026. Cancer Genet Cytogenet. 2007. PMID: 17889704

6

Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.

Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, Fu L, Hu L, Guan XY. Zhu C, et al. Among authors: guan xy. Oncogene. 2009 Aug 6;28(31):2821-8. doi: 10.1038/onc.2009.137. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525977

7

DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.

Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, Guan XY, Li Y. Zhou Y, et al. Among authors: guan xy. Oncogene. 2018 Feb 22;37(8):1086-1094. doi: 10.1038/onc.2017.383. Epub 2017 Nov 6. Oncogene. 2018. PMID: 29106393 Free PMC article.

8

Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.

Li XD, Zhang JX, Jiang LJ, Wang FW, Liu LL, Liao YJ, Jin XH, Chen WH, Chen X, Guo SJ, Zhou FJ, Zeng YX, Guan XY, Liu ZW, Xie D. Li XD, et al. Among authors: guan xy. Oncogene. 2016 Dec 8;35(49):6281-6292. doi: 10.1038/onc.2016.165. Epub 2016 May 16. Oncogene. 2016. PMID: 27181205

9

MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.

Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X, Zhao Z, Kong KL, Dong S, Song Y, Chan TH, Guan XY. Fan H, et al. Among authors: guan xy. Oncogene. 2012 May 3;31(18):2298-308. doi: 10.1038/onc.2011.411. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909138

10

EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.

Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, Liu TH, Bian XW, Guan XY, Lin MC, Zeng MS, Zeng YX, Kung HF, Xie D. Tong ZT, et al. Among authors: guan xy. Oncogene. 2012 Feb 2;31(5):583-94. doi: 10.1038/onc.2011.254. Epub 2011 Jun 20. Oncogene. 2012. PMID: 21685935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results